Other functions - contract orientation meeting with NCI, office of acquisitions
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,647
Award facts
- Opportunity
-
- N01CN2500278 Solicitation number
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
- Contract value 88% obligated
- $4,144.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$497 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,144 |
About this award
This federal contract award is for an "OTHER FUNCTIONS - CONTRACT ORIENTATION MEETING WITH NCI, OFFICE OF ACQUISITIONS" valued at $4,144.00. The award was made by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services, to the prime contractor Sri International, a non-profit research and development institute. The contract is a Delivery Order under the Preclinical Efficacy and Intermediate Endpoint Biomarkers contract vehicle. Sri International provides a wide range of scientific, engineering, and technical services to federal government agencies through contracts and grants, including substantial biomedical research for the Department of Health and Human Services. This award does not have a small business set-aside designation.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100001 worth?
The government has obligated $3,647 on HHSN26100001. Its current value, with exercised options, is $4,144.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201200014I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award